Confectioner Mars will today (Monday) unveil research showing that cocoa compounds could help treat diabetes, strokes and vascular disease, according to the Financial Times.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more


The findings, to be presented at a conference in Switzerland, hold out the prospect of a major new class of medications, the paper said. Mars has discovered how to replicate the cocoa compounds or flavanols. It is in discussions with pharmaceutical companies about licensing production of synthesised flavanols.


“The mounting evidence in cocoa flavanols is extraordinary,” said Norm Hollenberg, professor of medicine at Harvard Medical School, which shared some of the research with Mars. “This is a scientific breakthrough that could well lead to a medical breakthrough.”


“We have a valuable asset that’s not just about food, it’s about the pharmaceutical sector,” Mars chief science officer Harold Schmitz told the Financial Times. 

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Nominations Closed

Nominations are now closed for the Just Food Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Winning five categories in the 2025 Just Food Excellence Awards, Centric Software is setting the pace for digital transformation in food and FMCG. Explore how its integrated PLM and PXM suite delivers faster launches, smarter compliance and data-driven growth for complex, multi-channel product portfolios.

Discover the Impact